The aim of this commentary is to define strategies in MM patients, and explore how frailty assessment may be employed in clinical practice and clinical trials.
No takes yet. Share an insight, caveat, or question.
Engelhardt et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: